News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arch Pharmalabs Limited Eyes $100M by 2010 from DSM Deal


12/4/2007 7:24:47 AM

MUMBAI, Dec 4 (Reuters) - India's Arch Pharma Labs expects to get at least $100 million by 2010 from the bulk drug manufacture deal it has entered with Dutch chemicals group DSM (DSMN.AS: Quote, Profile, Research), a top official said on Tuesday.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES